Owner/Operator Of GenPharm Pharmacy In Dallas Area Pleads Guilty
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Owner/Operator Of GenPharm Pharmacy In Dallas Area Pleads Guilty

Owner/Operator Of GenPharm Pharmacy In Dallas Area Pleads Guilty

February 03, 2017
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Cynthia M. Velazquez
Phone Number: 571-324-7481

Operated a Pill Mill in Desoto, Texas: Three Defendants Previously Pled Guilty to Related Charges

DALLAS - A registered pharmacist who owned, operated and served as the pharmacist in charge of GenPharm Pharmacy on Wheatland Road in Desoto, Texas, Ndufola Kigham, appeared in federal court this morning before U.S. District Judge Sidney A. Fitzwater and pleaded guilty to federal felony offenses stemming from her involvement in a “pill mill” operation, announced U.S. Attorney John Parker of the Northern District of Texas.

Specifically, Kigham, 45, of Arlington, Texas, pleaded guilty to two counts of misprision of a felony.  She faces a maximum statutory penalty of three years in federal prison, on each of the two counts. In addition, according to the terms of her plea agreement, she agrees to pay a $9,500 fine prior to sentencing.  She will remain on bond pending sentencing, which is set for May 26, 2017.

After their arrests in January 2016, Kigham, along with another co-defendant pharmacist, Kumi Frimpong, and Dr. Richard Andrews, a doctor of osteopathy who supervised the McAllen Medical Clinic on South Hampton in Dallas, were ordered to surrender their Drug Enforcement (DEA) registration numbers, preventing Kigham and Frimpong from dispensing controlled substances and Dr. Andrews from issuing prescriptions for controlled substances. Kigham also surrendered the stock of controlled substances that she had in her pharmacy to DEA.

Dr. Andrews, 64, of Dallas, pleaded guilty in mid-January 2016 to one count of conspiracy to distribute controlled (oxycodone) and one count of conspiracy to launder monetary instruments.  According to the plea agreement filed in his case, if the Court accepts the plea, the parties agree that a sentence of at least 48 months but no more than 96 months in federal prison is the appropriate disposition of his case. He has agreed that he will not apply for another DEA Certificate of Registration, and he further agreed never to seek or retain employment, including consulting, in or related to the pain management industry.  He also agreed not to obtain or maintain, directly or indirectly, a financial ownership interest in a pain management clinic or home healthcare service.  He remains on bond pending sentencing, which is set for April 28, 2017.

Frimpong, 56, of Dallas, who owned, operated, and was the pharmacist in charge at Cornerstone Pharmacy, on Bolton Boone Drive in Desoto, pleaded guilty in September 2016 to one count of conspiracy to illegally distribute oxycodone. He also agreed to surrender $41,112 to the U.S. that constituted proceeds from dispensing oxycodone during the conspiracy. He faces a maximum statutory penalty of 20 years in federal prison and is scheduled to be sentenced on March 17, 2017.

According to plea documents filed in Kigham’s case, between approximately January 2013 and August 2014, several individuals conspired to distribute 30mg oxycodone, a Schedule II controlled substance.  Kigham admitted that she knew of the conspiracy and failed to notify any authority of it. Instead, she committed affirmative acts to conceal the conspiracy, such as filling prescriptions for 30mg oxycodone written for multiple different individuals and dispensing the filled prescriptions to a single individual, and not to the individuals named on the prescription. By filling these prescriptions while the conspiracy was ongoing, Kigham dispensed more than 70,000 30mg oxycodone pills based on legitimate prescriptions. 

Another co-conspirator in the case, Muhammad Faridi, 40, who is not a physician but who was the owner of the McAllen Medical Clinic, pleaded guilty in August 2016 to one count of conspiracy to launder monetary instruments and is scheduled to be sentenced in March 2017.   

In February 2015, a federal grand jury in Dallas indicted 23 individuals on offenses related to their participation in the prescription drug distribution conspiracy. That indictment alleged that from at least May 2013 through July 2014, the defendants participated in a scheme to illicitly obtain prescriptions for pain medications, such as oxycodone and hydrocodone, and then distribute those controlled substances for profit. As part of the conspiracy, individuals, often homeless or of limited means, were recruited and paid to pose as patients at medical clinics, including the McAllen Medical Clinic, to obtain prescriptions to fill those prescriptions at designated pharmacies.

Superseding indictments were returned in December 2015 and in January 2016, and a total of 31 individuals were charged. Many of those defendants have pleaded guilty and are awaiting sentencing.  Eleven have been sentenced to date. Trial for the one remaining defendant, Carolina Berrio, is set for April 10, 2017.

This Organized Crime Drug Enforcement Task (OCDETF) investigation is being conducted by the Drug Enforcement Administration and Internal Revenue Service Criminal Investigation, with assistance from the Texas Department of Public Safety, the Louisiana State Police, the Grand Prairie Police Department, the Dallas Police Department, the Houston Police Department, the Arlington Police Department, the Greenville Police Department, the Parker County Sheriff’s Office, the U.S. Marshal’s Service, the U.S. Postal Inspection Service, and the Diplomatic Security Service.

Assistant U.S. Attorney Mary Walters is in charge of the prosecution.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Eduardo A. Chávez Special Agent in Charge - Dallas
@DEADallasDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español